Shruti Chandra

Employment

• National Health Service

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• Infographic: MERCURY-3 clinical trial summary
  Eye 2025 DOI: 10.1038/s41433-025-03953-5
  +Save
• Determinants of Visual Functions in Patients with Early and Intermediate Age-related Macular Degeneration: the PEONY study
  2025 DOI: 10.21203/rs.3.rs-6178391/v1
  +Save
• Photoreceptor assessment in age-related macular degeneration
  Eye 2025 DOI: 10.1038/s41433-024-03462-x
  +Save
• Determinants of visual functions in patients with early and intermediate age-related macular degeneration: the PEONY study
  Eye 2025 DOI: 10.1038/s41433-025-03931-x
  +Save
• The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
  Eye 2024 DOI: 10.1038/s41433-024-03214-x
  +Save
• Subretinal transient hyporeflectivity in neovascular age-related macular degeneration and its response to a loading phase of aflibercept: PRECISE report 4
  Eye 2024 DOI: 10.1038/s41433-024-03087-0
  +Save
• Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3
  Eye 2024 DOI: 10.1038/s41433-023-02886-1
  +Save
• Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2
  Eye 2024 DOI: 10.1038/s41433-023-02769-5
  +Save
• Tyrosine Kinase Inhibitors and their role in treating neovascular age-related macular degeneration and diabetic macular oedema
  Eye 2023 DOI: 10.1038/s41433-023-02610-z
  +Save
• Perspectives from clinical trials: is geographic atrophy one disease?
  Eye 2023 DOI: 10.1038/s41433-022-02115-1
  +Save